Our Pricing

Compare Mounjaro Prices for Weight Loss Treatment

When comparing mounjaro prices uk comparison options, transparency matters. At Cured Pharmacy, Mounjaro (tirzepatide) starts from £135.00 with upfront pricing shown before your free consultation with a UK prescriber. Our GPhC-registered pharmacy guarantees genuine UK-licensed medication, discreet packaging, and clinical support throughout your weight loss journey.

Understanding Mounjaro Pricing in the UK

Mounjaro pricing varies significantly across UK pharmacies, with monthly costs typically reflecting the prescribed dose strength and pharmacy dispensing fees. At Cured Pharmacy, we display transparent pricing from £135.00 before you begin your consultation, eliminating surprise costs at checkout. Your final prescription cost depends on the dose your UK prescriber determines is clinically appropriate following your medical assessment.

Unlike some providers who advertise low entry prices but add hidden consultation fees or delivery charges, our pricing structure includes your medication, prescriber review, and discreet UK delivery. Superintendent Pharmacist Tarun Kumar (GPhC 2233073) oversees all dispensing to ensure you receive genuine Eli Lilly–manufactured Mounjaro KwikPens, not compounded alternatives or unlicensed imports.

Mounjaro is available in five dose strengths (2.5mg, 5mg, 7.5mg, 10mg, and 15mg), with treatment typically starting at the lowest dose and titrating upward every four weeks as tolerated [1]. This gradual escalation minimises gastrointestinal side effects whilst allowing your prescriber to identify the optimal therapeutic dose for sustained weight loss.

How Mounjaro (Tirzepatide) Delivers Superior Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. This dual-action mechanism sets it apart from single-pathway treatments like semaglutide (Wegovy) or liraglutide (Saxenda), activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously.

In the landmark SURMOUNT-1 trial, participants receiving the highest tirzepatide dose (15mg) achieved an average body weight reduction of 22.5% over 72 weeks — significantly exceeding results seen with semaglutide-based therapies in head-to-head comparisons [1][2]. The dual receptor activation enhances satiety signalling, slows gastric emptying, and improves insulin sensitivity more effectively than GLP-1 agonism alone.

Clinical data demonstrates that tirzepatide produces dose-dependent weight loss, with higher maintenance doses correlating with greater total body weight reduction [1]. Your UK prescriber will monitor your progress through follow-up consultations, adjusting your dose to balance efficacy with tolerability whilst working toward your individualised weight loss goals.

Expected Results and Timeline

Most patients begin noticing appetite suppression within the first week of Mounjaro treatment, though measurable weight loss typically becomes evident after 4-8 weeks as doses escalate [1]. The SURMOUNT trials showed that maximum weight loss occurred between weeks 60-72, emphasising that tirzepatide is a long-term treatment requiring consistent adherence rather than a rapid-fix solution.

Individual results vary based on baseline BMI, adherence to lifestyle modifications, and metabolic factors. Your prescriber will assess your progress at regular intervals, and treatment continuation depends on demonstrating clinically meaningful weight loss (typically at least 5% body weight reduction after 12 weeks at maintenance dose) as per NICE guidance [3].

Mounjaro vs Wegovy: Clinical Comparison

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are once-weekly injectable medications licensed in the UK for chronic weight management, but they differ in mechanism, efficacy profile, and clinical trial outcomes. Wegovy activates only GLP-1 receptors, whilst Mounjaro's dual GIP/GLP-1 action produces enhanced metabolic effects in comparative studies [2][4].

The STEP trials demonstrated that semaglutide 2.4mg (Wegovy) produced an average 14.9% body weight reduction over 68 weeks, whilst tirzepatide 15mg achieved 22.5% reduction in SURMOUNT-1 [1][2]. Both medications show similar side effect profiles dominated by gastrointestinal symptoms (nausea, diarrhoea, constipation), though individual tolerance varies significantly between patients.

Your choice between these treatments depends on clinical factors including your weight loss goals, previous treatment responses, medical history, and cost considerations. Some patients who don't achieve adequate results with semaglutide-based treatments may respond better to tirzepatide's dual-receptor mechanism, though this requires prescriber assessment and cannot be predicted in advance.

Which Treatment Is Right for You?

Your UK prescriber will evaluate your BMI, weight-related comorbidities (such as type 2 diabetes, hypertension, or sleep apnoea), previous weight loss attempts, and contraindications before recommending the most appropriate medication. Patients with type 2 diabetes may particularly benefit from tirzepatide's superior glycaemic control effects demonstrated in the SURPASS trial programme [4].

Cost considerations also factor into treatment selection. Whilst Mounjaro represents a higher investment compared to some alternatives, many patients find the enhanced efficacy justifies the price difference when pursuing significant, sustained weight loss under medical supervision.

Alternative Weight Loss Treatments at Cured Pharmacy

Beyond Mounjaro, Cured Pharmacy offers a comprehensive range of MHRA-licensed weight loss treatments to suit different clinical needs and budgets. Wegovy (semaglutide) provides robust once-weekly injectable therapy, whilst Saxenda (liraglutide) offers daily injection flexibility for patients who prefer more frequent dosing with shorter action duration.

For patients seeking non-injectable options, we dispense Orlistat (available as generic, Xenical, or Alli formulations) and Mysimba tablets. Orlistat works through a different mechanism entirely — blocking dietary fat absorption in the intestine rather than affecting appetite hormones — making it suitable for patients who cannot tolerate GLP-1 medications or prefer oral therapy [5].

The newly available Wegovy oral tablets (semaglutide pill) represent an innovative option for patients wanting GLP-1 therapy without injections, though this formulation requires specific administration instructions to ensure adequate absorption. Your prescriber will discuss which treatment aligns best with your medical profile, lifestyle preferences, and weight loss objectives during your consultation.

Mounjaro Prices UK Comparison: What Affects Cost

Several factors influence mounjaro prices uk comparison across different providers. Dose strength represents the primary variable — higher maintenance doses (10mg and 15mg) cost more than starter doses (2.5mg and 5mg) due to the greater quantity of active pharmaceutical ingredient per pen. Treatment duration also affects total investment, as most patients require 6-12 months of therapy to achieve and consolidate clinically significant weight loss.

Pharmacy dispensing fees, prescriber consultation charges, and delivery costs create additional price variation across UK providers. Some pharmacies advertise attractive headline prices but add substantial consultation fees or require expensive ongoing subscription models. At Cured Pharmacy, our transparent pricing structure includes all clinical services, with no hidden charges appearing at checkout.

Supply chain factors occasionally impact availability and pricing across the UK pharmacy sector. Cured Pharmacy maintains direct relationships with licensed wholesalers to ensure consistent stock of genuine Eli Lilly Mounjaro pens, minimising treatment interruptions that can compromise your weight loss progress. Our lowest price guarantee means you're getting competitive UK pricing without sacrificing quality or clinical support.

Insurance and Private Prescription Costs

Mounjaro is not routinely available through NHS prescription for weight loss, meaning most UK patients access it privately. Some private health insurance policies may cover weight management medications for patients with obesity-related comorbidities, though coverage varies significantly between insurers and policy types. Check your specific policy documents or contact your insurer directly to determine eligibility.

Private prescription costs at Cured Pharmacy are clearly displayed before you complete your consultation, allowing you to make informed decisions about treatment affordability. We require no long-term subscription commitments — you can order month-by-month based on your prescriber's recommendations and personal circumstances.

Starting Your Mounjaro Treatment at Cured Pharmacy

Beginning Mounjaro treatment at Cured Pharmacy takes under three minutes through our streamlined online consultation process. You'll complete a medical questionnaire covering your weight history, current medications, relevant health conditions, and weight loss goals. A UK-registered prescriber reviews your submission, typically within 24 hours, and approves your prescription if clinically appropriate.

Once approved, our GPhC-registered pharmacy team dispenses your medication in discreet, unmarked packaging for next-day delivery across the UK. Your first prescription typically covers the initial dose-escalation phase, with follow-up consultations scheduled to assess tolerance and adjust dosing as you progress through the titration schedule outlined in the product licence [1].

Ongoing support from our clinical team ensures you're never navigating treatment alone. You can contact our pharmacists with questions about injection technique, side effect management, or treatment expectations. Superintendent Pharmacist Tarun Kumar oversees all clinical queries, providing expert guidance throughout your weight loss journey. All prescription medications require assessment by a UK prescriber before dispensing, and treatment continuation depends on demonstrating adequate response and tolerability.

What to Expect After Ordering

After your prescriber approves your Mounjaro prescription, we dispatch your medication via tracked courier for discreet delivery to your specified address. Each KwikPen arrives with comprehensive patient information leaflets, injection instructions, and sharps disposal guidance to ensure safe, effective self-administration.

Your treatment package includes access to our clinical support line for any questions arising during treatment. We'll also schedule follow-up consultations at appropriate intervals to monitor your progress, assess for side effects, and adjust your prescription as needed. Consistent communication with your prescriber optimises outcomes and ensures Mounjaro remains safe and effective for your individual circumstances.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management. NICE guideline [CG189]. https://www.nice.org.uk/guidance/cg189
4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
5. Sjöström, L., Rissanen, A., Andersen, T., et al. (1998). Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. The Lancet, 352(9123), 167–172. https://doi.org/10.1016/S0140-6736(97)11509-4

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment and lifestyle modifications.